CURRENT REGULATORY REQUIREMENTS FOR ASEPTICALLY PRODUCED PRODUCTS

Posted By : User Ref No: WURUR70159 0
  • Image
  • TypeWebinar
  • Image
  • Location Dufferin, Ontario, Canada
  • Price
  • Date 02-12-2020
CURRENT REGULATORY REQUIREMENTS FOR ASEPTICALLY PRODUCED PRODUCTS, Dufferin, Ontario, Canada
Webinar Title
CURRENT REGULATORY REQUIREMENTS FOR ASEPTICALLY PRODUCED PRODUCTS
Event Type
Webinar
Webinar Date
02-12-2020
Last Date for Applying
01-12-2020
Location
Dufferin, Ontario, Canada
Organization Name / Organize By
Eventura World
Presented By
Kenneth Christie
Sponsored By
Eventura World
Organizing/Related Departments
Quality
Organization Type
Training/Development
WebinarCategory
Both (Technical & Non Technical)
WebinarLevel
All (State/Province/Region, National & International)
Related Industries

Education/Teaching/Training/Development

Research/Science

Manufacturing

Medical/Healthcare/Hospital

Location
Dufferin, Ontario, Canada

Description

The manufacture of sterile products, whether by aseptic means or terminal sterilization, requires a thorough understanding of applicable regulations by the FDA and those by the EU if selling your products overseas. In addition, there are various guidance documents that address other issues such as closure integrity and sterility test methods that were recently revised.

Today, the regulatory requirements for sterile products are found in a “Guidance for Industry” document that was published in 2004. In addition, there are requirements found in 21 CFR 210-211 and 820. In all of these documents, the areas of importance and audit focus are:

  • Equipment, utility and facility qualifications
  • Validation of all sterilization processes
  • Control of the environment and potential sources of contamination
  • Personnel training and gowning requirements based on defined areas of cleanliness
  • Laboratory controls and
  • Process simulations designed to verify the acceptability of the manufacturing process and operator activities.

This webinar will discuss the most important issues that apply to sterile products in order to provide an overview for attendees to evaluate their own processes and procedures. It will not go into detail on the various sterilization methods that are used within the industry, nor will it detail how best to establish process simulations. Recent 483 observations will be reviewed to help highlight common industry deficiencies and as a reference to compare attendees current practices.

Areas Covered in the Session :

  • Review the current regulatory requirements and guidance documents dealing with sterile products
  • Review the expectations for aseptically produced products.
  • Discuss the six quality systems that are reviewed during regulatory inspections
  • Review common deficiencies cited with the manufacture of sterile drugs
  • Review the importance of personnel training and control of microbiological contamination

Who Should Attend:

  • Drug Manufacturers
  • Contract Manufacturing Companies
  • Sterile Product Vendors
  • Quality Assurance Departments
  • Quality Control Departments
  • Manufacturing Departments
  • Validation Departments
  • Production Departments
  • Regulatory Departments

Others Details

Online Event

Registration Fees
Available
Registration Fees Details
Live- Single $200.00 Live Corporate $700.00
Registration Ways
Email
Phone
Website
Address/Venue
  Online Event 
Official Email ID
Contact
Komala

5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada

[email protected]

     +1-416-915-4458